| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000021129 |
| Receipt No. | R000024259 |
| Scientific Title | A multi-center, randomized controlled trial comparing early versus elective colonoscopy in outpatients with acute lower gastrointestinal bleeding |
| Date of disclosure of the study information | 2016/02/21 |
| Last modified on | 2019/09/24 (Ver. 16) |
| Basic information | ||
| Public title | A multi-center, randomized controlled trial comparing early versus elective colonoscopy in outpatients with acute lower gastrointestinal bleeding | |
| Acronym | Early colonoscopy trial | |
| Scientific Title | A multi-center, randomized controlled trial comparing early versus elective colonoscopy in outpatients with acute lower gastrointestinal bleeding | |
| Scientific Title:Acronym | Early colonoscopy trial | |
| Region |
|
|
| Condition | ||
| Condition | Acute lower gastrointestinal bleeding | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate stigmata recent of hemorrhage rate of early versus elective colonoscopy in outpatient with acute lower gastrointestinal bleeding. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | Phase III |
| Assessment | |
| Primary outcomes | Stigmata recent of hemorrhage rate in lower gastrointestinal tract |
| Key secondary outcomes | Success rate of endoscopic treatment, need for additional endoscopic examination, need for interventional radiology, need for surgery, 30 day rebleeding rates, length of stay, 30 day thrombosis events, 30 day mortality, preparation related adverse events (nausea, vomitting, abdominal pain, volume overload, aspiration pnumonia, hemorrhagic shock, exacerbation bleeding, and ileus), and colonoscopy related adverse events (hemorrhagic shock, and perforation). |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | YES |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Early colonoscopy: performing prepared
colonoscopy within 24 h on arrival. |
|
| Interventions/Control_2 | Elective colonoscopy: performing prepared colonoscopy between 24 and 96 h on arrival. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Inclusion criteria
1.Adults aged>=20 years presenting moderate to severe hematochezia or melena within 24 h on arrival, defined as (i) more than 3 bloody bowel movements within 8 h; (ii) hemorrhagic shock; or (iii) requiring transfusion. 2.All patients were able to provide informed consent. |
|||
| Key exclusion criteria | Exclusion criteria
1.Patients with hematemesis, black vomiting, or melena. 2.Upper gastrointestinal bleeding patients who diagnosed by nasogastric tube or upper endoscopy. 3.Patients who had impossible consumed the oral bowel preparation solution. 4.Patients who received computed tomography. 5.Patients who diagnosed peptic ulcer diseases within 10 days. 6.Ulcerative colitis, or Crohn diseases patients. 7.Patients who received abdominal surgery. 8.Patients who received polypectomy, endoscopic mucosal resection, or endoscopic submucosal dissection of the colon within 10 days. 9.Patients with suspected perforation, or peritonitis. 10.Patients with suspected intestinal obstruction. 11.Patients with hemorrhagic shock refractory to infusion or blood transfusion. 12.Patients who received total colectomy. 13.Patients with suspected disseminated intravascular coagulation. 14.Patients with end stage malignant disease. 15.Patients with severe cardiac failure. 16.Patients with active thrombosis. 17.Patients with severe respiratory failure. 18.Pregnant patients. |
|||
| Target sample size | 162 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Graduate School of Medicine, The University of Tokyo | ||||||
| Division name | Department of Gastroenterology | ||||||
| Zip code | 1138655 | ||||||
| Address | 7-3-1 Hongo, Bunkyo-ku, Tokyo | ||||||
| TEL | 03-3815-5411 | ||||||
| yamada-a@umin.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Graduate School of Medicine, The University of Tokyo | ||||||
| Division name | Department of Gastroenterology | ||||||
| Zip code | 1138655 | ||||||
| Address | 7-3-1 Hongo, Bunkyo-ku, Tokyo | ||||||
| TEL | 03-3815-5411 | ||||||
| Homepage URL | |||||||
| rniikura@triton.ocn.ne.jp | |||||||
| Sponsor | |
| Institute | Graduate School of Medicine, The University of Tokyo |
| Institute | |
| Department | |
| Funding Source | |
| Organization | The Japanese Gastroenterological Association |
| Organization | |
| Division | |
| Category of Funding Organization | Non profit foundation |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | The University of Tokyo, Clinical Research Review Board |
| Address | 7-3-1, Hongo, Bunkyo-ku, Tokyo |
| Tel | 03-5800-8743 |
| crctky-office@umin.ac.jp | |
| Secondary IDs | |
| Secondary IDs | YES |
| Study ID_1 | NCT 03098173 |
| Org. issuing International ID_1 | ClinicalTrials.gov |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 東京大学医学部附属病院
国立国際医療研究センター病院 石川県立中央病院 聖路加国際病院 国立国際医療研究センター国府台病院 小樽掖済会病院 市立豊中病院 国立病院機構函館病院 斗南病院 福井県立病院 弘前大学医学部附属病院 愛知県がんセンター 長崎みなとメディカルセンター市民病院 周東総合病院 地域医療機能推進機構大阪病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | http://www.todai-shoukakan.com/cont4/29.html |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024259 |